This Project Grant award of $509,683.37 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support a translational research program focused on understanding individual differences in risk for alcohol use disorder (AUD). The program aims to translate a preclinical model of individual differences in the attribution of incentive salience (IS) to reward-predictive cues into a human laboratory model examining individual...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $481,428 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the Moses-Weitzman Health System, Inc. on September 20, 2024. The project, titled "Translating Research into Practice on Alcohol and Polysubstance Use Disorders by Educating the Interprofessional Primary Care Team," aims to improve the capacity of primary care providers in federally qualified health centers and other safety net settings to...
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development of an undergraduate research program at Rutgers, The State University of New Jersey. The $524,272 award aims to promote the advancement of students from underrepresented groups in the field of addiction research through the "Training in Research Undergraduate Experience through the Rutgers Addiction Research...
This Project Grant award, funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program, aims to investigate the neural mechanisms driving adaptive stress coping behaviors and subsequent alcohol use. The $498,121.57 award, effective August 15, 2024 through July 31, 2027, will utilize an animal model to explore how dysfunction in the corticolimbic circuitry, specifically the prelimbic cortex and basolateral...
This Federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under their Alcohol Research Programs (CFDA 93.273), provides $155,996 to Rutgers, The State University to conduct research on "Vascular Reactivity to Compounding Stressors Across the Blood Alcohol Curve: Interactions with Chronic Drinking and Polysubstance Use." The research aims to identify early biomarkers of alcohol's effects on the vasculature to help address the public health...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a Project Grant under the Alcohol Research Programs (CFDA 93.273) to the University of Illinois. The $293,128 grant, awarded on August 23, 2024, will fund a study examining the neural correlates of alcohol reward in social contexts using a hyperscanning EEG setup. The research aims to evaluate the neural mechanisms underlying the rewarding effects of alcohol in social settings and assess how individual and group-level factors...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $209,145 in funding to the Georgia State University Research Foundation Inc. to support the "Alcohol Prevention Research on Violence, Equity, and Novel Techniques (A-PREVENT) Training Program." The program aims to train a new generation of prevention scientists adept at developing multilevel interventions targeting the...
This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to the Scripps Research Institute provides $288,107 in funding from July 1, 2025 to June 30, 2030. The grant supports a predoctoral training program to develop a new generation of leaders in addiction research, equipped with technical skills and expertise in team science to translate research targets into potential treatments. The program combines a core of expert mentors...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $537,587 Project Grant under the Alcohol Research Programs (CFDA 93.273) to The University of Texas Southwestern Medical Center to conduct research on the metabolic consequences of liver inflammation on alcohol consumption and alcohol-associated liver disease (ALD). The key objectives are to identify the mechanisms by which the transcription factor IRF3 suppresses the expression and secretion of the metabolic regulator...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $1,547,718 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) from September 1, 2024 to May 31, 2029. The project will investigate the role of KDM5 demethylases in regulating cell-cell communication in the development and resolution of alcohol-associated liver disease. Specifically, the research aims to determine how KDM5B and KDM5C...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), provides $175,372 in funding to Rutgers, The State University of New Jersey to support a 5-year training program focused on the etiology and consequences of alcohol use across the lifespan. The program will train 4 postdoctoral fellows annually at the Rutgers Addiction Research Center, which is the largest comprehensive addiction research center in the U.S. The training will be led by 11 core faculty mentors and supported by 9 additional domain experts, covering topics such as the biological, psychological, and social mechanisms underlying alcohol use and related conditions like trauma, mental health, and behavioral addictions. Trainees will receive customized methodological training in areas like genomic analysis, digital health, and intervention design, as well as professional development support to launch their scientific careers in alcohol research.